Company profile: AccessClosure
1.1 - Company Overview
Company description
- Provider of access site management products for vascular closure during interventional and diagnostic procedures, including the Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble, extravascular sealant.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AccessClosure
Coherex Medical
HQ: United States
Website
- Description: Provider of medical devices addressing structural heart disease, including a patent foramen ovale (PFO) closure system designed to stimulate tissue in-growth for long-term closure, and the WaveCrest Left Atrial Appendage Occlusion System to close the left atrial appendage and reduce stroke risk in atrial fibrillation patients who cannot tolerate chronic oral anticoagulation therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coherex Medical company profile →
Corvia Medical
HQ: United States
Website
- Description: Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF ≥40%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corvia Medical company profile →
New Valve Technology
HQ: Switzerland
Website
- Description: Provider of medical devices for interventional cardiology and cardiac surgery, supporting minimally invasive treatment of valvular heart disease; develops, manufactures and markets these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full New Valve Technology company profile →
Reva Medical
HQ: United States
Website
- Description: Provider of bioresorbable polymers and medical devices for vascular applications, including MOTIV Bioresorbable Scaffold for below-the-knee peripheral artery disease, Fantom Encore third-generation radiopaque coronary scaffold with thin struts, and TyroSphere bioresorbable embolic microspheres for hypervascular tumors, visible under standard x-ray; all built on the proprietary Tyrocore polymer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reva Medical company profile →
Esperion Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical products for cardiovascular and metabolic diseases, including bempedoic acid to lower LDL-cholesterol in hypercholesterolemia patients inadequately treated with current lipid-modifying therapies, and a fixed-dose combination of bempedoic acid and ezetimibe to further reduce LDL-cholesterol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Esperion Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AccessClosure
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AccessClosure
2.2 - Growth funds investing in similar companies to AccessClosure
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AccessClosure
4.2 - Public trading comparable groups for AccessClosure
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →